Pharmaniaga held its 27th Annual General Meeting on 18 June 2025 at the Royale Ballroom, Level 2, Royale Chulan Damansara in Petaling Jaya. Every attendee received a RM 50 voucher for the hotel's Royale Coffee House. The meeting covered the usual agenda like directors’ re-elections, approval for fees and allowances, adoption of financial statements for the year ending 31 December 2024, and special resolutions for share issuance, buy back, and related party mandates.
Pharmaniaga Berhad is a Malaysian pharmaceutical company headquartered in Shah Alam, Selangor It operates in manufacturing, logistics/distribution, and in Indonesia via subsidiaries. In FY 2023, it reported revenues around RM 3.4 billion and a net income of about RM 78.7 million . More recently, the company posted a small Q1 2025 net profit of roughly RM 29.6 million on RM 1.05 billion in revenue
Its key business lines include:
- Manufacture and marketing of prescription drugs, over‑the‑counter products, and biopharmaceuticals .
- Logistics and distribution of pharmaceuticals and medical supplies.
- Operations in Indonesia through PT Millennium Pharmacon and PT Errita, producing generics and OTC items .